1. Drug utilization and morbidity statistics for the evaluation of drug safety in Sweden;Wiholm, B.E.; Westerholm, B.;Acta Med Scand,1984
2. Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2;Jackson, J.E.; Bressler, R.;Drugs,1981
3. The acute and chronic effects of sulphonylurea therapy in type 2 diabetic subjects;Kolterman, O.G.; Gray, R.S.; Shapiro, G.; Scarlett, J.A.; Griffin, J.; Olefsky, J.M.;Diabetes,1985
4. Tolbutamide stimulation and inhibition of insulin release. Studies of the underlying ionic mechanisms in isolated rat islets;Henquin, J.C.;Diabetologia,1980
5. Glibenclamide-associated hypoglycaemia: a report on 57 cases;K, S.Asplund; BE, Wiholm; F, Lithner;Diabetologia,1983